Amelia Morrone Selected Research

Amelia Morrone Research Topics

Disease

11	Fabry Disease (Fabry's Disease) 01/2021 - 10/2004
8	GM1 Gangliosidosis (Gangliosidosis GM1) 08/2022 - 07/2003
7	Gaucher Disease (Gaucher's Disease) 01/2024 - 09/2015
4	Mucopolysaccharidosis IV (Morquio Syndrome) 01/2021 - 07/2011
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 12/2023 - 02/2007
3	Congenital Disorders of Glycosylation 12/2023 - 02/2022
3	Metabolic Diseases (Metabolic Disease) 12/2023 - 03/2011
3	Mucopolysaccharidoses 11/2018 - 11/2014
3	Medium chain acyl CoA dehydrogenase deficiency 01/2013 - 01/2003
2	Cholestasis 01/2022 - 01/2022
2	Liver Failure 01/2022 - 01/2022
2	Gangliosidoses (Gangliosidosis) 01/2021 - 10/2020
2	Mucolipidoses (Sialidosis) 01/2020 - 11/2009
2	Neuraminidase deficiency with beta-galactosidase deficiency 11/2019 - 08/2013
2	Disease Progression 11/2019 - 10/2017
2	Cardiomyopathies (Cardiomyopathy) 04/2018 - 02/2013
2	Hyperammonemia 01/2018 - 05/2013
2	Inborn Urea Cycle Disorders 01/2018 - 05/2013
2	Coma (Comas) 05/2013 - 01/2012
2	Fructose Intolerance (Intolerance, Fructose) 01/2012 - 02/2008
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2011 - 01/2011
1	Amish Infantile Epilepsy Syndrome 05/2024
1	Ischemic Stroke 01/2024
1	Cerebral Hemorrhage 01/2024
1	Neuralgia (Stump Neuralgia) 12/2023
1	Neoplasms (Cancer) 12/2023
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 08/2022
1	Type I 3-Methylglutaconic Aciduria 04/2022
1	Hemochromatosis (Bronze Diabetes) 01/2022
1	Neonatal hemochromatosis 01/2022
1	Congenital central hypoventilation syndrome 01/2022
1	Cerebrotendinous Xanthomatosis 01/2022
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2022
1	Atrophy 08/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 08/2021
1	Cerebellar Diseases (Cerebellar Syndrome) 08/2021
1	Ataxia (Dyssynergia) 08/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2021
1	Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset) 12/2020
1	Sphingolipidoses (Sphingolipidosis) 10/2020
1	Edema (Dropsy) 01/2020
1	Intellectual Disability (Idiocy) 01/2020
1	Splenomegaly 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Uniparental Disomy 10/2018
1	Headache (Headaches) 01/2018

Drug/Important Bio-Agent (IBA)

22	EnzymesIBA 01/2024 - 10/2004
9	GalactosidasesIBA 01/2024 - 08/2013
7	alpha-Galactosidase (Beano)IBA 06/2018 - 10/2004
5	Glucosylceramidase (Glucocerebrosidase)IBA 01/2024 - 09/2015
5	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2007
4	Messenger RNA (mRNA)IBA 10/2018 - 04/2006
3	G(M1) GangliosideIBA 08/2022 - 11/2019
3	HydrolasesIBA 01/2021 - 11/2008
3	beta-Galactosidase (Lactaid)IBA 01/2021 - 01/2005
3	miglustat (Zavesca)FDA Link 10/2020 - 10/2017
3	AcidsIBA 01/2020 - 09/2015
3	GlucosidasesIBA 01/2020 - 09/2015
3	GlycosphingolipidsIBA 11/2019 - 11/2008
3	Fatty Acids (Saturated Fatty Acids)IBA 06/2016 - 10/2012
2	RNA (Ribonucleic Acid)IBA 05/2024 - 12/2023
2	Glucosylceramides (Glucocerebrosides)IBA 01/2024 - 01/2020
2	GlycoconjugatesIBA 03/2023 - 10/2020
2	globotriaosylceramide (globotriosylceramide)IBA 01/2021 - 07/2016
2	Neuraminidase (Sialidase)IBA 01/2020 - 08/2013
2	Amino Acids FDA Link 01/2018 - 07/2011
2	AmmoniaIBA 01/2018 - 05/2013
2	N-acetyl glutamate synthetase deficiencyIBA 01/2018 - 05/2013
2	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2012 - 02/2008
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2024
1	LipidsIBA 12/2023
1	piperidineIBA 04/2023
1	Leucine (L-Leucine)FDA Link 04/2022
1	methylglutaconyl-CoA hydrataseIBA 04/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2022
1	SteroidsIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	polyalanineIBA 01/2022
1	Congenital disorder of glycosylation type 1AIBA 08/2021
1	GangliosidesIBA 01/2021
1	NitrogenIBA 01/2021
1	globotriaosyl lysosphingolipidIBA 01/2021
1	CarbonIBA 01/2021
1	GlycolipidsIBA 01/2021
1	AminesIBA 10/2020
1	Lysergic Acid Diethylamide (LSD)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	GlycosaminoglycansIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Keratan SulfateIBA 10/2018

Therapy/Procedure

5	Therapeutics 12/2023 - 07/2015
2	Enzyme Replacement Therapy 01/2017 - 10/2004
2	Ligation 01/2016 - 01/2012
1	Secondary Prevention 08/2022
1	Liver Transplantation 01/2022
1	Activities of Daily Living (ADL) 08/2021
1	Drug Therapy (Chemotherapy) 11/2019
1	Treatment Delay 01/2018